文献速递神经肿瘤

全脑放疗与预防性颅脑照射中的海马保护:系统综述与荟萃分析

Hippocampal avoidance in whole brain radiotherapy and prophylactic cranial irradiation: a systematic review and meta-analysis.
PubMed 文献 · J Neurooncol · 2023-07-03

该系统综述与荟萃分析检索PubMed并遵循PRISMA,纳入19项研究共1611例脑转移患者,评估海马保护性全脑放疗和/或预防性颅脑照射。海马复发率低(总体效应量=0.04,95%CI [0.03, 0.05]),5项比较海马保护与常规放疗的研究间复发风险无显著差异(风险差=0.01,95%CI [-0.02, 0.03],p=0.63);认知功能、记忆和言语学习在放疗后3-24个月出现显著差异。

要点

  • 海马保护性全脑放疗/预防性颅脑照射后海马复发率低,总体效应量=0.04(95%CI [0.03, 0.05])。
  • 5项比较海马保护与常规放疗的研究间海马复发风险无显著差异(风险差=0.01,95%CI [-0.02, 0.03],p=0.63)。
  • 19项研究中11项包含神经认知测试,整体认知功能、记忆和言语学习在放疗后3-24个月报告显著差异。

核心结论

  • 当前海马保护性全脑放疗/预防性颅脑照射研究显示海马复发或转移率低。
  • 神经认知测试的显著差异最突出于整体认知功能、记忆和言语学习。
  • 研究受失访影响。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed并遵循PRISMA指南筛选文献。
  • 共纳入19篇文章、1611例患者,其中7项随机对照试验、4项前瞻性队列研究、8项回顾性队列研究。
  • 所有研究评估脑转移患者的海马保护性全脑放疗和/或预防性颅脑照射。
  • 分析指标包括中位总生存期、无进展生存期、海马复发率和神经认知功能测试。

主要发现

  • 海马复发率低,总体效应量=0.04(95%CI [0.03, 0.05])。
  • 5项比较海马保护性全脑放疗/预防性颅脑照射与常规全脑放疗/预防性颅脑照射的研究间,海马复发风险无显著差异(风险差=0.01,95%CI [-0.02, 0.03],p=0.63)。
  • 19项研究中11项包含神经认知功能测试,整体认知功能、记忆和言语学习在放疗后3-24个月报告显著差异。
  • 一项研究(Brown等)在4个月时报告执行功能差异。
  • 无研究报告任何时间点言语流畅性、视觉学习、注意力、处理速度和精神运动速度的差异。

局限性

  • 研究受失访影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We systematically reviewed the current landscape of hippocampal-avoidance radiotherapy, focusing specifically on rates of hippocampal tumor recurrence and changes in neurocognitive function. METHODS: PubMed was queried for studies involving hippocampal-avoidance radiation therapy and results were screened using PRISMA guidelines. Results were analyzed for median overall survival, progression-free survival, hippocampal relapse rates, and neurocognitive function testing. RESULTS: Of 3709 search results, 19 articles were included and a total of 1611 patients analyzed. Of these studies, 7 were randomized controlled trials, 4 prospective cohort studies, and 8 retrospective cohort studies. All studies evaluated hippocampal-avoidance whole brain radiation treatment (WBRT) and/or prophylactic cranial irradiation (PCI) in patients with brain metastases. Hippocampal relapse rates were low (overall effect size = 0.04; 95% confidence interval [0.03, 0.05]) and there was no significant difference in risk of relapse between the five studies that compared HA-WBRT/HA-PCI and WBRT/PCI groups (risk difference = 0.01; 95% confidence interval [- 0.02, 0.03]; p = 0.63). 11 out of 19 studies included neurocognitive function testing. Significant differences were reported in overall cognitive function and memory and verbal learning 3-24 months post-RT. Differences in executive function were reported by one study, Brown et al., at 4 months. No studies reported differences in verbal fluency, visual learning, concentration, processing speed, and psychomotor speed at any timepoint. CONCLUSION: Current studies in HA-WBRT/HA-PCI showed low hippocampal relapse or metastasis rates. Significant differences in neurocognitive testing were most prominent in overall cognitive function, memory, and verbal learning. Studies were hampered by loss to follow-up.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Leskinen S, Shah HA, Yaffe B, et al. Hippocampal avoidance in whole brain radiotherapy and prophylactic cranial irradiation: a systematic review and meta-analysis. J Neurooncol. 2023. PMID: 37395975. doi:10.1007/s11060-023-04384-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。